Mergers & Acquisitions (M&A) related activities – A Regulatory Affairs perspective

Duration: 1 hour


Registration

If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.


Why watch

 Key Learnings

  •  Overview of M&A related Regulatory activities (Pre – and Post-Merger)
  •  The role of Regulatory Affairs in the execution of these Projects / activities
  •  Challenges and some “tips” for successful execution of these activities
speakers

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.



Dr. Adam King

Senior Director Regulatory Affairs, PharmaLex

Dr. King has nearly 30 years of experience working in the pharma industry, with +18 years regulatory affairs experience both in a global R&D environment and more recently regulatory consultancy.